Evidence map›Paper›PMID 34447454›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2021

Review on the Antibacterial Mechanism of Plant-Derived Compounds against Multidrug-Resistant Bacteria (MDR).

Najwan Jubair, Mogana Rajagopal, Sasikala Chinnappan, Norhayati Binti Abdullah, Ayesha Fatima

Abstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Najwan JubairFaculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia.ORCID https://orcid.org/0000-0003-3492-7181
Mogana RajagopalFaculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia.ORCID https://orcid.org/0000-0002-5664-9293
Sasikala ChinnappanFaculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia.ORCID https://orcid.org/0000-0002-7565-8662
Norhayati Binti AbdullahForest Research Institute Malaysia (FRIM), Kuala Lumpur 52109, Selangor, Malaysia.ORCID https://orcid.org/0000-0002-6916-9870
Ayesha FatimaBeykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-3181-2680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial resistance has progressed rapidly and is becoming the leading cause of death globally. The spread of antibiotic-resistant microorganisms has been a significant threat to the successful therapy against microbial infections. Scientists have become more concerned about the possibility of a return to the pre-antibiotic era. Thus, searching for alternatives to fight microorganisms has become a necessity. Some bacteria are naturally resistant to antibiotics, while others acquire resistance mainly by the misuse of antibiotics and the emergence of new resistant variants through mutation. Since ancient times, plants represent the leading source of drugs and alternative medicine for fighting against diseases. Plants are rich sources of valuable secondary metabolites, such as alkaloids, quinones, tannins, terpenoids, flavonoids, and polyphenols. Many studies focus on plant secondary metabolites as a potential source for antibiotic discovery. They have the required structural properties and can act by different mechanisms. This review analyses the antibiotic resistance strategies produced by multidrug-resistant bacteria and explores the phytochemicals from different classes with documented antimicrobial action against resistant bacteria, either alone or in combination with traditional antibiotics.

Identifiers

PMID34447454
PMCPMC8384518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.